How Much Did Phage Lab Raise?
Funding & Key Investors

Phage Lab, a pioneer in precision bacteriophage therapeutics, has successfully secured a major strategic investment, bringing its total capital accumulation to $11M. This latest injection of $11M underscores the growing institutional confidence in the company's proprietary platform, which leverages over a decade of epidemiological data to address bacterial challenges in the livestock sector. By securing this financing, the firm is well-positioned to scale its operations and solidify its footprint in the global biotechnology landscape.

The recent capital infusion marks a pivotal moment for the Santiago-based enterprise, as it transitions from a research-heavy development phase into a broader commercialization strategy. With operations spanning Chile, Spain, and Brazil, Phage Lab is effectively positioning itself as a critical player in the movement to reduce antibiotic reliance in industrial breeding processes.